ArticleInternational forum of allergy & rhinology2025

Persistent Eosinophilic Inflammation Is Not a Feature of Type 2 CRS Patients Failing Anti-IL-5R Therapy and Requiring Class Switching to Anti-IL-4/13.

Peta-Lee Sacks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.